Captor Capital Corp.

CSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeCSE

Market Capitalization1.92 mln

Float3.43 mln

Piotroski F-Score

4 / 9

Borderline

Relative Strength

11 / 100

Significantly lagging

Debt / Equity

0.08

Debt-free

Pre-Tax Margin

419%

Exceptional margin

ROE

-48.49

Deeply negative

ROA

-43.96

Deeply negative

Key Fundamentals

EPS-1.62

ROE-48.49

ROIC-497

ROA-43.96

EBITDA, mln-5.22

EV / EBITDA1.03

EV / EBIT1.03

Quote Details

Last 0.40

Change 0.13 (48.15%)

Open 0.40

Volume 600

Turnover 240

Average Volume 8,970

Financial Ratios

Pre-Tax Profit Margin419

Leverage Ratio1.08

Current Ratio6.95

Price / Book0.23

Price / Tangible Book0.23

Debt / Equity0.08

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-20%	10 / 100
1 Month	-11.11%	71 / 100